Integra LifeSciences Holdings Corporation
IART
$13.05
-$0.01-0.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.88% | -1,813.86% | -230.14% | 281.70% | 13.76% |
| Total Depreciation and Amortization | 2.20% | 1.36% | -16.78% | 24.27% | 21.17% |
| Total Amortization of Deferred Charges | -30.42% | 36.46% | -1.07% | 4.87% | -8.56% |
| Total Other Non-Cash Items | -103.78% | 402,841.88% | 104.18% | 62.75% | -136.22% |
| Change in Net Operating Assets | 234.75% | 26.86% | -105.67% | -453.29% | 261.73% |
| Cash from Operations | 358.64% | 179.23% | -122.19% | 125.66% | -44.35% |
| Capital Expenditure | 24.77% | 30.34% | 2.30% | 0.16% | 0.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.24% | 78.54% | -133.07% | 9.96% | 283.39% |
| Cash from Investing | 27.99% | 39.73% | -745.38% | 59.13% | 96.77% |
| Total Debt Issued | 4,579.84% | -76.29% | 53.67% | 62.39% | -62.93% |
| Total Debt Repaid | -3,762.72% | -4.22% | 61.84% | 3.85% | 54.12% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | 55.38% | 79.12% | 18.07% | -1,424.56% | 99.66% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.58% | -581.00% | -- | -- | 100.00% |
| Cash from Financing | 51.54% | -159.75% | 594.78% | 64.10% | 78.76% |
| Foreign Exchange rate Adjustments | -106.32% | 179.93% | 155.76% | -204.85% | 788.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.35% | -191.43% | -123.29% | 39,616.46% | 99.98% |